Status
Terminated
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.
Status
Terminated
Classification
Class I
Report Date
November 27, 2013
Termination Date
November 27, 2013